Related Experiment Videos
[Abnormal uterine hemorrhage in climacteric. Medical management]
M Porpiglia1, R Piacentino, A Cellura
1Dipartimento di Scienze Ginecologiche Ostetriche, Università degli Studi, Torino.
Insights
Current menopause treatments for anomalous uterine bleeding are reviewed. While a perfect solution is elusive, specialists must carefully select and sequence therapies for optimal patient outcomes.
Area of Science:
- Gynecology
- Pharmacology
- Menopause Research
Context:
- Anomalous uterine bleeding (AUB) is a common concern during menopause.
- Management of AUB in menopausal women presents significant challenges.
Purpose:
- To review current pharmacological treatments for AUB in menopausal women.
- To illustrate the aims and rationale behind existing AUB treatment strategies.
- To highlight the complexities in achieving satisfactory treatment outcomes.
Summary:
- A literature review was conducted to identify and analyze drugs used for menopausal AUB.
- The study details the therapeutic goals and underlying scientific principles for each drug class.
- Findings indicate that achieving complete resolution of AUB is often difficult.
Impact:
- Provides a comprehensive overview of AUB pharmacotherapy in menopause.
- Informs clinical decision-making for gynecologists and endocrinologists.
- Underscores the need for individualized treatment approaches by specialists.
Abstract:
Following a review of the literature, the authors examine the drugs which are currently used to treat anomalous uterine bleeding during menopause, illustrating their aims and justifying the rationale underlying their use. They conclude by stating that a satisfactory treatment often does not exist, but it is the task of the specialist to gauge the level and sequence of treatments in order to achieve the hoped-for result.